| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biologics: the next generation of analgesic drugs?
|
Chessell, Iain P.
|
|
2012
|
17 |
15-16 |
p. 875-879
5 p.
|
artikel
|
| 2 |
Can network pharmacology rescue neutraceutical cancer research?
|
Azmi, Asfar S.
|
|
2012
|
17 |
15-16 |
p. 807-809
3 p.
|
artikel
|
| 3 |
Cell-penetrating peptides: classes, origin, and current landscape
|
Milletti, Francesca
|
|
2012
|
17 |
15-16 |
p. 850-860
11 p.
|
artikel
|
| 4 |
Characteristics of rare disease marketing applications associated with FDA product approvals 2006–2010
|
Pariser, Anne R.
|
|
2012
|
17 |
15-16 |
p. 898-904
7 p.
|
artikel
|
| 5 |
Contents
|
|
|
2012
|
17 |
15-16 |
p. i-
1 p.
|
artikel
|
| 6 |
Contents
|
|
|
2012
|
17 |
15-16 |
p. iii-
1 p.
|
artikel
|
| 7 |
DNA polymerase beta (pol β) inhibitors: A comprehensive overview
|
Barakat, Khaled H.
|
|
2012
|
17 |
15-16 |
p. 913-920
8 p.
|
artikel
|
| 8 |
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
|
Di, Li
|
|
2012
|
17 |
15-16 |
p. 905-912
8 p.
|
artikel
|
| 9 |
Fluorine local environment: from screening to drug design
|
Vulpetti, Anna
|
|
2012
|
17 |
15-16 |
p. 890-897
8 p.
|
artikel
|
| 10 |
Microtissue size and hypoxia in HTS with 3D cultures
|
Asthana, Amish
|
|
2012
|
17 |
15-16 |
p. 810-817
8 p.
|
artikel
|
| 11 |
Network analysis has diverse roles in drug discovery
|
Hasan, Samiul
|
|
2012
|
17 |
15-16 |
p. 869-874
6 p.
|
artikel
|
| 12 |
Physiological, pathological and potential therapeutic roles of adipokines
|
Falcão-Pires, Inês
|
|
2012
|
17 |
15-16 |
p. 880-889
10 p.
|
artikel
|
| 13 |
Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure
|
Higgins, John
|
|
2012
|
17 |
15-16 |
p. 828-836
9 p.
|
artikel
|
| 14 |
R&D investments for neglected diseases can be sensitive to the economic goal of pharmaceutical companies
|
Dimitri, Nicola
|
|
2012
|
17 |
15-16 |
p. 818-823
6 p.
|
artikel
|
| 15 |
Strategic alliances and market risk
|
Havenaar, Matthias
|
|
2012
|
17 |
15-16 |
p. 824-827
4 p.
|
artikel
|
| 16 |
Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries
|
Arachchige Don, Aruni S.
|
|
2012
|
17 |
15-16 |
p. 861-868
8 p.
|
artikel
|
| 17 |
Translation of drug effects from experimental models of neuropathic pain and analgesia to humans
|
Taneja, Amit
|
|
2012
|
17 |
15-16 |
p. 837-849
13 p.
|
artikel
|
Tijdschrift beschrijving